Kritika Singh

Kritika Singh

Auto-generated profile, based on publicly available information

Kritika Singh

Division of Genetic Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2022 in Molecular Psychiatry
Verified
Journal Article
Closed access
PDF file
GPGita A. Pathak
Gita A. Pathak
KSKritika Singh
Kritika Singh
Frank WendtFrank Wendt
Frank Wendt
TFTyne W. Fleming
Tyne W. Fleming
COCassie Overstreet
Cassie Overstreet
RPRenato Polimanti
Renato Polimanti

5 July 2024 in medRxiv
Verified
Preprint
Open access
PDF file
NSNora I. Strom
Nora I. Strom
BVBrad Verhulst
Brad Verhulst
SBSilviu-Alin Bacanu
Silviu-Alin Bacanu
RCRosa Cheesman
Rosa Cheesman
KPKirstin L. Purves
Kirstin L. Purves
JHJohn M. Hettema
John M. Hettema
The major anxiety disorders (ANX; including generalized anxiety disorder, panic disorder, and phobias ) are highly prevalent, often onset early, persist throughout life, and cause substantial global disability. Although distinct in their clinical presentations, they likely represent differential expressions of a dysregulated threat-response system. Here we present a genome-wide association meta-analysis comprising 122,341 European ancestry ANX cases and 729,881 controls. We identified 58 independent genome-wide significant ANX risk variants and 66 genes with robust biological support. In an independent sample of 1,175,012 self-report ANX cases and 1,956,379 controls, 51 of the 58 associated variants were replicated. As predicted by twin studies, we found substantial genetic correlation between ANX and depression, neuroticism, and other internalizing phenotypes. Follow-up analyses demonstrated enrichment in all major brain regions and highlighted GABAergic signaling as one potential mechanism underlying ANX genetic risk. These results advance our understanding of the genetic architecture of ANX and prioritize genes for functional follow-up studies.

2 February 2024 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
KSKritika Singh
Kritika Singh
Frank WendtFrank Wendt
Frank Wendt
The internalizing spectrum encompasses a subset of psychopathologies characterized by emotional liability, anhedonia, anxiousness, distress, and fear, and includes, among others, diagnoses of major depressive disorder (MDD), generalized anxiety disorder (GAD), and posttraumatic stress disorder (PTSD). In this review, we describe the vast body of work highlighting a role for sex and gender in the environment, symptom onset, genetic liability, and disorder progression and comorbidities of MDD, GAD, and PTSD. We also point the reader to different language used in diverse fields to describe sexual and gender minorities that may complicate the interpretation of emerging literature from the social sciences, psychiatric and psychological sciences, and genetics. Finally, we identify several gaps in knowledge that we hope serve as launch-points for expanding the scope of psychiatric studies beyond binarized sex-stratification. Despite being under-represented in genomics studies, placing emphasis on inclusion of sexual and gender diverse participants in these works will hopefully improve our understanding of disorder etiology using genetics as one tool to inform how biology (e.g., hormone concentration) and environmental variables (e.g., exposure to traumatic events) contribute to differences in symptom onset, pattern, and long-term trajectory.

23 December 2021 in Journal of Biological Chemistry
Verified
Journal Article
Open access
EOEmily M. Overway
Emily M. Overway
KBKarin J. Bosma
Karin J. Bosma
DCDerek P. Claxton
Derek P. Claxton
JOJames K. Oeser
James K. Oeser
KSKritika Singh
Kritika Singh
RORichard M. O'BRien
Richard M. O'BRien
G6PC2 encodes a glucose-6-phosphatase (G6Pase) catalytic subunit that modulates the sensitivity of insulin secretion to glucose and thereby regulates fasting blood glucose (FBG). A common single-nucleotide polymorphism (SNP) in G6PC2, rs560887 is an important determinant of human FBG variability. This SNP has a subtle effect on G6PC2 RNA splicing, which raises the question as to whether nonsynonymous SNPs with a major impact on G6PC2 stability or enzyme activity might have a broader disease/metabolic impact. Previous attempts to characterize such SNPs were limited by the very low inherent G6Pase activity and expression of G6PC2 protein in islet-derived cell lines. In this study, we describe the use of a plasmid vector that confers high G6PC2 protein expression in islet cells, allowing for a functional analysis of 22 nonsynonymous G6PC2 SNPs, 19 of which alter amino acids that are conserved in mouse G6PC2 and the human and mouse variants of the related G6PC1 isoform. We show that 16 of these SNPs markedly impair G6PC2 protein expression (>50% decrease). These SNPs have variable effects on the stability of human and mouse G6PC1, despite the high sequence homology between these isoforms. Four of the remaining six SNPs impaired G6PC2 enzyme activity. Electronic health record–derived phenotype analyses showed an association between high-impact SNPs and FBG, but not other diseases/metabolites. While homozygous G6pc2 deletion in mice increases the risk of hypoglycemia, these human data reveal no evidence that the beneficial use of partial G6PC2 inhibitors to lower FBG would be associated with unintended negative consequences.

10 October 2022 in medRxiv
Verified
Preprint
Open access
PDF file
JJJiayue-Clara Jiang
Jiayue-Clara Jiang
KSKritika Singh
Kritika Singh
LDLea K. Davis
Lea K. Davis
NWNaomi R. Wray
Naomi R. Wray
SSSonia Shah
Sonia Shah
Background: The lack of research on female-specific risk factors for cardiovascular diseases (CVD) has led to sex-based disparities in cardiovascular health. Though epidemiological studies show increased CVD risks amongst individuals with psychiatric disorders, findings on sex differences in comorbidity have been inconsistent. Methods: This genetic epidemiology study examined the sex-specific association between the genetic risk of three psychiatric disorders [major depression (MD), schizophrenia and bipolar disorder], estimated using polygenic scores (PGS), and risks of three CVDs [atrial fibrillation (AF), coronary artery disease (CAD) and heart failure (HF)] in 345,169 European-ancestry individuals (UK Biobank), with analyses replicated in an independent BioVU cohort (N=49,057). Mediation analysis was conducted to determine whether traditional CVD risk factors could explain any observed sex difference. Results: In UK Biobank, PGS MD was significantly associated with the incident risks of all three CVDs in females after multiple testing correction [hazard ratio (HR) AF-female =1.04 (95% CI: 1.02-1.06; p=0.00015); HR CAD-female =1.07 (1.04-1.11; p=2.6E-06); HR HF-female =1.09 (1.06-1.13; p=9.7E-10)], but not in males. These female-specific associations remained even in the absence of any psychiatric disorder diagnosis or psychiatric medication use. Although mediation analysis demonstrated that the association between PGS MD and CVDs in females was partly mediated by baseline BMI, hypercholesterolemia, hypertension and smoking, these risk factors did not explain the higher risk compared to males. The association between PGS MD and CAD was consistent between females who were pre-menopausal and post-menopausal at baseline (mean baseline age of 44.9 and 60.8 years, respectively), while the association with AF and HF was only observed in the baseline post-menopausal cohort. No significant association with CVD risks was observed for the PGS of schizophrenia or bipolar disorder. The positive association of PGS MD with CAD and HF risk in females was replicated in BioVU, where the corresponding associations in males also reached nominal significance. Conclusions: Genetic predisposition to MD confers a greater risk of CVDs in females versus males, even in the absence of any depression diagnosis. This study warrants further investigation into whether genetic predisposition to depression could be useful for improving cardiovascular risk prediction even in the absence of a depression diagnosis, especially in women.

5 April 2024 in Nature Mental Health
Verified
Journal Article
Closed access
PDF file
KSKritika Singh
Kritika Singh
HLHyunjoon Lee
Hyunjoon Lee
JSJulia M. Sealock
Julia M. Sealock
TMTyne Miller-Fleming
Tyne Miller-Fleming
PSPeter Straub
Peter Straub
LDLea K. Davis
Lea K. Davis